Using a linear correlation approach between immunotype and the SGR for each tumor, we observed tumor growth inhibition was most strongly correlated with higher levels of HLA-DR+TIM-3-TNFα+ and TNFα+IFNγ+ CD4+ T cells. The gene discussed is HAVCR2; the disease is neoplasm.